Table 2

Anti-HBV serological markers in different clinical stages of hepatitis C virus related chronic liver disease

  • Values represent percentages of the total number of patients in each group. Values in parentheses show the actual number of patients (patients with anti-HBc positive/total patients). HBV, hepatitis B virus; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma; anti-HBs, antibody to hepatitis B surface antigen; anti-HBc, antibody to hepatitis B core antigen. *Significantly higher than LC or CH group (p<0.01).